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ase of use has dictated the destiny of all new techniques
nd devices in interventional cardiology. The popularity of
tents began when they became as easy to use and more
redictable than balloons. Conversely, directional and rota-
ional atherectomy fell into oblivion or became confined to
small niche application. Some of these devices have been
nderused, even when proved beneficial, such as filters in
aphenous vein graft treatment or thrombectomy in acute
yocardial infarction. For chronic total occlusions (CTOs),
he only route to success passes through the use of multiple
edicated wires, guided by contralateral injection, and of
ver-the-wire (OTW) balloons or microcatheters, some-
imes inserted retrogradely via collateral vessels with the use
f devices with exotic names like Tornus and Corsair (Asahi
ntecc, Nagoya, Japan).
See page 479
No wonder few interventionalists have ventured into this
ncharted territory. The problem is, however, that CTOs
re very frequent and are present in 30% of patients with
ignificant coronary stenoses and almost 50% of patients
ith multivessel disease. Failure to tackle these lesions
eans high rates of surgical referral or, worse, incomplete
ercutaneous revascularization, with long-term results that
re bound to be no better than medical therapy (1) and
orse than surgery (2).
After the publication of SYNTAX (Synergy between PCI
ith Taxus and Cardiac Surgery) (3), to support a greater
ole of percutaneous coronary intervention in multivessel
nd left main disease, we examined every fraction of
ercentage difference in death, stroke, and new revascular-
zation in the 1,800 patients randomized. Maybe we also
hould have paid equal attention to the 1,077 suitable
atients screened who went straight to surgery because they
ere deemed unsuitable for angioplasty, mainly because of
omplex CTOs.
The SYNTAX study was conducted in some of the best
enters on both sides of the Atlantic and 24.2% of these
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-c
ions or the American College of Cardiology.
From the Royal Brompton Hospital, Clinical Cardiology, London, England.atients with 3-vessel disease or left main disease in the
ercutaneous coronary intervention (PCI) arm had at least 1
TO. When we see the real-world practice, as observed in
he National Cardiovascular Data Registry quoted in this
ice review (4), the attempt rate in CTOs is 13.6% in the
.S. Our Japanese colleagues report and give continuous
onvincing demonstrations in live courses that CTOs can be
uccessfully opened in 90% of cases with a low complica-
ion rate and excellent long-term patency with the use of
rug-eluting stents (5). Unlike primary angioplasty for
T-segment elevation myocardial infarction and prompt
nvasive treatment of acute coronary syndromes, elective
ngioplasty in patients with stable angina or silent ischemia
oes not reduce mortality, with the possible exception of
TO recanalization. The advantages in recovery of left
entricular function and late survival were consistently
onfirmed in addition to the expected relief of symptoms
nd reduced need of coronary artery bypass grafting, as
icely reported in this updated review from Grantham et al.
6) in this issue of JACC: Cardiovascular Interventions.
Then, why don’t we do more? The answer is simple: a
ack of training and insufficient volume to maintain and
ncrease specific CTO experience. The apprenticeship is the
ornerstone of training in interventional cardiology, like in
ost “surgical” specialties. You do not learn how to open
TOs from watching live cases lasting hours in courses or
istening to experts presenting new techniques and devices.
ou need to work hands-on, first assisting and later being
ssisted by experienced surgeons to gain the confidence to
ush the wire into the unknown, to keep drilling and
teering it along the virtual track you expect the vessel to
ollow until you meet the distal end of the occlusion. You
eed to learn to immediately detect when your wire is
eflected toward the subintima and then stop, without
eopardizing your chances of success by creating large
issections, sometimes switching to a new parallel wire that
ill be guided by the position of the first wire in a false
rack. You need to learn to avoid too many useless antero-
rade injections and to select the best views for each
egment, switching to orthogonal views when needed. If
ou want to add another 10% to 15% success rate and tackle
ome “impossible” CTOs, you need to learn to patiently
ngage collaterals, visualize them subselectively, and master
ew wires, long balloons, and dedicated devices to support
heir progression to the distal end of the occlusion and
eyond (7).
In Europe, we often show contempt for what we term the
low-volume American operators.” In reality I have seen
any well-respected, high-volume catheter laboratories in
urope in which the use of OTW balloons, microcatheters,
ontralateral injection, anchor balloons, and trapping bal-
oons, the cornerstone of CTO treatment, is watched with
mixture of curiosity and amazement by the staff. If the case
ontinues beyond 1 to 2 h, everyone starts pointing to
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488igh-radiation doses or contrast use as valid reasons to stop.
olume is not equal to quality, and quickly performing
any angioplasties does not mean an operator is proficient
hen he or she treats different an animal like the CTO. For
technique such as interventional cardiology, which is
ecoming more and more complex, spanning from struc-
ural heart disease and peripheral interventions to acute and
hronic coronary syndromes, we should apply the Roman
otto, or the title of this editorial, “Ars longa, vita brevis”:
ife is too short to learn all the tricks and subtleties of this
raft, and we should not pretend to be the best in every
spect but rather concentrate in 1 or 2 selected fields in
hich we can become truly good and proficient.
How and when do we learn these new skills? Do not
xpect to learn them as a young trainee. Before you begin
andling complex CTOs, you need a minimum background
f 500 to 1,000 “normal” PCIs to master guiding support,
elivery of balloons and stents around calcific bends, proper
esion preparation, side branch protection, and stent expan-
ion. When you reach the point, you can start advanced
TO training. As a respected young independent operator,
ou have to think hard and decide whether you are mas-
chistic enough to accept to go back to training and learn a
echnique that often requires spending long hours in surgery
nd where you still have a chance at the end to face the
atient and say, “Sorry, I failed.” You should also check your
olume of angioplasty procedures and have a frank discus-
ion with your colleagues to see whether you can have and
aintain the anticipated volume of referrals to ensure that
ou perform a minimum of 50 to 100 cases/year (7). Because
ime in the catheter laboratories is limited, you are likely to
erform fewer cases than your colleagues, an annoying
roblem if you and your center are compensated by number
f procedures because you will become the black sheep,
onsuming too many resources to produce not enough
evenue.
If you are still committed to go ahead and specialize in
TO treatment, you have to find a practical and effective
ay to do it. The easiest way is to already practice in a
atheter laboratory at which other CTO operators are
illing to teach. The alternative is to go to other catheter
aboratories once a week or once in a fortnight, possibly
ringing there your most complex CTOs, a routine that
hould include at least 50 to 100 cases, which may mean 1
o 2 years during which time you will be mainly watching
nd assisting. This experience can be a frustrating one, but
t also can become very rewarding if you develop good dooperation and learn team work. The ability to discuss and
lternate as an operator with another experienced colleague
uring these long interventions is also helpful to maintain
ocus, improve success, and reduce complications.
Even when you have completed your specific training,
ou have to accept that you have never finished learning in
field in which the success rate is still far from 100% and
ould be much lower if many CTOs were not avoided at
his stage. This rate explains the continuous proliferation of
ew devices and techniques to improve outcome. Maybe
ou are tempted to wait until CTO treatment becomes as
asy and predictable as a computer war game, where we fire
aser or radiofrequency energy from the control room using
3-dimensional reconstruction of the occluded vessels for
uidance. Do not wait too long: unfortunately, this is not
appening soon and your CTO patients desperately need
hese procedures now.
eprint requests and correspondence: Dr. Carlo Di Mario,
oyal Brompton Hospital, Clinical Cardiology, Sydney Street,
ondon SW3 6NP, England. E-mail: c.dimario@rbht.nhs.uk.
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